绥美凯（多替阿巴拉米片）上市没？

(Dotiabalamid Tablets) is a complete single-tablet three-in-one preparation with DTG as the core. It can be taken once a day, one pill at a time, without considering factors such as food, environment, location, etc. AIDS is generally recognized as a chronic disease. For chronic diseases, patient compliance is particularly important. Suimeike (Doteta abalamib tablets) is taken once a day, one tablet at a time, which reduces the frequency and dosage of medication and significantly enhances patient compliance. Today we are going to find out whether Suimeikai (Doteta Abalamid Tablets) is on the market? 

Trimicay (dolutegravir) is a once-daily three-in-one drug developed by ViiV Healthcare, a joint venture between GlaxoSmithKline and Pfizer. The drug is based on the treatment plan of the integrase inhibitor Tivicay (Dolutegravir) and also contains two nucleoside reverse transcriptase inhibitors, Abacavir and Lamivudine. It was approved by the FDA on August 27, 2014. 

Subsequently, on January 22, 2018, GlaxoSmithKline (GSK) announced that its single-tablet compound preparation Trimeq (dolute abalamib tablets) with the new generation integrase inhibitor dolutegravir (DTG) as the core for the treatment of HIV was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

Suimeikai (dolute abalamib tablets) has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. Suimeikai (dolute abalamib tablets) is a new drug used to treat AIDS without considering food effects. For adults and adolescents weighing 40kg or more, the recommended dosage of Trimax (dolutea is one tablet, once daily). Because Trimax is a fixed-dose tablet and the dose cannot be reduced, adults or adolescents who weigh less than 40 kg should not be given Trimax. Before taking Suimeike (Dolutea Paramid Tablets), you need to complete the test to determine whether you carry the special type of "HLA-B*5701" gene.

The above is the content of the launch of (Doteta Abalamid Tablets), I hope it can help you!